← All certifications
biotechnology

Biotechnology Intellectual Property Portfolio Management

This course provides legal and scientific professionals with the expertise to navigate the complexities of patent prosecution and life science intellectual property strategy. It focuses on the intersection of novel therapeutic discovery and the legal requirements for securing global exclusivity.

Advanced 24 hours 4.8 (0 reviews) 0 enrolled

£580

Certified Biotech Intellectual Property Professional

  • Pass mark 70%
  • Certificate on completion
  • Verifiable public certificate ID
  • English · available globally
Direct answers

Biotechnology Intellectual Property Portfolio Management: the short answers

What is Biotechnology Intellectual Property Portfolio Management?
This course provides legal and scientific professionals with the expertise to navigate the complexities of patent prosecution and life science intellectual property strategy. It focuses on the intersection of novel therapeutic discovery and the legal requirements for securing global exclusivity.
Who is Biotechnology Intellectual Property Portfolio Management for?
It is pitched at Advanced level for Biotech Patent Attorneys working in biotechnology, and is studied online from any country.
How long does Biotechnology Intellectual Property Portfolio Management take?
Around 24 hours of study, plus the assessed assignments and one applied project.
How is the certification assessed?
Every assignment and the final project are assessed automatically against the published criteria. The pass mark is 70%, and an item that does not pass can be resubmitted.
What do I receive when I pass?
Certified Biotech Intellectual Property Professional, issued as a certificate with a unique ID that employers can check in the public certificate register.
How much does it cost?
£580 once, with no subscription.

What you will be able to do

  • Analyze complex biotechnology patent landscapes for freedom-to-operate assessments
  • Draft technical patent claims that account for biological sequence variants
  • Implement internal documentation workflows to ensure robust research record-keeping for patent litigation
  • Evaluate the patentability of gene-editing technologies and novel delivery vectors
  • Manage global patent filing timelines in alignment with clinical development milestones

Written by Dr. Elena Vance, JD, Senior Counsel in Biopharm. Every submission is assessed automatically against the published criteria for Certified Biotech Intellectual Property Professional, and the certificate is issued the moment the assessment is complete.

20 topics in this subject area

Each topic is written to be read on its own. Open a topic to read its description.

The curriculum for this course is being written. Sign in to start reading.

Curriculum builder

Course Builder

Prepare your assignments and one applied project in your own words and submit them here. The AI assesses each piece as soon as you submit it, and your certificate is issued immediately once the assessment is complete.

Sign in to read the topics, write your assignments and project, and receive your certificate the moment the AI assessment is complete.